Type 2 diabetes patients 'ignore blood sugar after cancer diagnosis'

30 November 2012

When people with type 2 diabetes are diagnosed with cancer, they typically begin to ignore their diabetes treatment in order to focus on combating the cancer, new research has found.

However, it is important to warn these patients against doing so because uncontrolled high blood sugar is more likely to kill them, and it impairs the ability of their immune system to fight cancer.

People with type 2 diabetes are more at risk from cancer than the general population, note the authors of the study, which was conducted at Northwestern University.

The research found that after people with type 2 diabetes received education about diabetes after a cancer diagnosis, they were more likely to look after their blood sugar.

This resulted in fewer trips to the emergency room, a reduced number of hospital admissions, lower health care costs and increased blood sugar testing, compared to people who did not undergo the operation.

Posted by Edward Bartel

Health News is provided by Adfero in collaboration with Spire Healthcare. Please note that all copy above is ©Adfero Ltd. and does not reflect views or opinions of Spire Healthcare unless explicitly stated. Additional comments on the page from individual Spire consultants do not necessarily reflect the views or opinions of other consultants or Spire Healthcare.


Find a treatment, test or scan available at:


Find a consultant

Use one or more of the options below to search for a consultant and link through to view their Spire profile.


Let us help you

fill out this form and we will get back to you:

Please select a hospital

We can call you

Please enter your details below and we will call you back.

What is the aim of your enquiry?

Please select a hospital

If we are unable to reach you by phone, please include your email address so that we can get in touch...



© Spire Healthcare Group plc (2016)